Matrix Metalloproteinase Proteolysis of the Myelin Basic Protein Isoforms Is a Source of Immunogenic Peptides in Autoimmune Multiple Sclerosis
暂无分享,去创建一个
Piotr Cieplak | Boris I. Ratnikov | Jeffrey W. Smith | A. Strongin | P. Cieplak | B. Ratnikov | A. Savinov | K. Motamedchaboki | Alexei Y. Savinov | Alex Y. Strongin | S. Shiryaev | Sergey A. Shiryaev | Khatereh Motamedchaboki
[1] L. Steinman,et al. Antigen Specific Immunotherapy of Multiple Sclerosis , 2001, Journal of Clinical Immunology.
[2] C. Campagnoni,et al. Strain-related differences in the ability of T lymphocytes to recognize proteins encoded by the golli-myelin basic protein gene , 1996, Journal of Neuroimmunology.
[3] A. Ferrando,et al. Human MT6-matrix metalloproteinase: identification, progelatinase A activation, and expression in brain tumors. , 2000, Cancer research.
[4] C. López-Otín,et al. Collagenase-2 Deficiency or Inhibition Impairs Experimental Autoimmune Encephalomyelitis in Mice* , 2008, Journal of Biological Chemistry.
[5] Lawrence Steinman,et al. Multiple sclerosis: a two-stage disease , 2001, Nature Immunology.
[6] H. Hartung,et al. New concepts in the immunopathogenesis of multiple sclerosis , 2002, Nature Reviews Neuroscience.
[7] C. Campagnoni,et al. Human T lymphocytes specific for the immunodominant 83–99 epitope of myelin basic protein: Recognition of golli MBP HOG 7 , 1996, Journal of neuroscience research.
[8] A. Waisman,et al. Major T-cell responses in multiple sclerosis. , 1995, Molecular medicine today.
[9] S. Shapiro,et al. An elevated matrix metalloproteinase (MMP) in an animal model of multiple sclerosis is protective by affecting Th1/Th2 polarization , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[10] Z. Werb,et al. New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.
[11] Helga E. de Vries,et al. Matrix metalloproteinase-12 is expressed in phagocytotic macrophages in active multiple sclerosis lesions , 2003, Journal of Neuroimmunology.
[12] E. Sercarz,et al. A public T cell clonotype within a heterogeneous autoreactive repertoire is dominant in driving EAE. , 2007, The Journal of clinical investigation.
[13] N. Zečević,et al. Expression of Golli proteins in adult human brain and multiple sclerosis lesions , 2002, Journal of Neuroimmunology.
[14] Rosamund C Smith,et al. MMP-28 as a regulator of myelination , 2008, BMC Neuroscience.
[15] G J Barton,et al. Application of multiple sequence alignment profiles to improve protein secondary structure prediction , 2000, Proteins.
[16] R. Rudick,et al. Axonal transection in the lesions of multiple sclerosis. , 1998, The New England journal of medicine.
[17] C. Overall,et al. Subcellular Distribution and Cytokine- and Chemokine-regulated Secretion of Leukolysin/MT6-MMP/MMP-25 in Neutrophils* , 2001, The Journal of Biological Chemistry.
[18] C. Campagnoni,et al. The human myelin basic protein gene is included within a 179-kilobase transcription unit: expression in the immune and central nervous systems. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[19] Y. Masuho,et al. Membrane‐type 6 matrix metalloproteinase (MT6‐MMP, MMP‐25) is the second glycosyl‐phosphatidyl inositol (GPI)‐anchored MMP , 2000, FEBS letters.
[20] H. D. de Vries,et al. Matrix metalloproteinase‐19 is highly expressed in active multiple sclerosis lesions , 2006, Neuropathology and applied neurobiology.
[21] D. Arnold,et al. Induction of antigen-specific tolerance in multiple sclerosis after immunization with DNA encoding myelin basic protein in a randomized, placebo-controlled phase 1/2 trial. , 2007, Archives of neurology.
[22] M. Bernardo,et al. MT4-(MMP17) and MT6-MMP (MMP25), A unique set of membrane-anchored matrix metalloproteinases: properties and expression in cancer , 2008, Cancer and Metastasis Reviews.
[23] W. Baumgärtner,et al. MMP-12, MMP-3, and TIMP-1 Are Markedly Upregulated in Chronic Demyelinating Theiler Murine Encephalomyelitis , 2006, Journal of neuropathology and experimental neurology.
[24] T. Owens,et al. Downregulation of membrane type-matrix metalloproteinases in the inflamed or injured central nervous system , 2007, Journal of Neuroinflammation.
[25] C. G. Knight. [6] Active-site titration of peptidases , 1995 .
[26] E. Bongarzone,et al. New insights on the biology of myelin basic protein gene: The neural‐Immune connection , 2000, Journal of neuroscience research.
[27] J. S. Sodhi,et al. Prediction and functional analysis of native disorder in proteins from the three kingdoms of life. , 2004, Journal of molecular biology.
[28] M. Moscarello,et al. Differences in Susceptibility of MBP Charge Isomers to Digestion by Stromelysin-1 (MMP-3) and Release of an Immunodominant Epitope , 2006, Neurochemical Research.
[29] C. Weber,et al. MMP25 (MT6-MMP) Is Highly Expressed in Human Colon Cancer, Promotes Tumor Growth, and Exhibits Unique Biochemical Properties* , 2007, Journal of Biological Chemistry.
[30] Ji-Ming Feng. Minireview: Expression and Function of Golli Protein in Immune System , 2007, Neurochemical Research.
[31] H. Mcdevitt,et al. Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention , 1988, Cell.
[32] H. McFarland,et al. Epitope spreading occurs in active but not passive EAE induced by myelin basic protein , 1996, Journal of Neuroimmunology.
[33] V. Yong,et al. Expression and regulation of matrix metalloproteinase-12 in experimental autoimmune encephalomyelitis and by bone marrow derived macrophages in vitro , 2008, Journal of Neuroimmunology.
[34] C. Campagnoni,et al. Embryonic Expression of the Myelin Basic Protein Gene: Identification of a Promoter Region That Targets Transgene Expression to Pioneer Neurons , 1998, The Journal of Neuroscience.
[35] C. Campagnoni,et al. Structure and developmental regulation of Golli-mbp, a 105-kilobase gene that encompasses the myelin basic protein gene and is expressed in cells in the oligodendrocyte lineage in the brain. , 1993, The Journal of biological chemistry.
[36] A. Strongin,et al. Determination of matrix metalloproteinase activity using biotinylated gelatin. , 2000, Analytical biochemistry.
[37] Theodore V. Tselios,et al. Design of novel cyclic altered peptide ligands of myelin basic protein MBP83-99 that modulate immune responses in SJL/J mice. , 2008, Journal of medicinal chemistry.
[38] Vasso Apostolopoulos,et al. Design and synthesis of a novel potent myelin basic protein epitope 87-99 cyclic analogue: enhanced stability and biological properties of mimics render them a potentially new class of immunomodulators. , 2005, Journal of medicinal chemistry.
[39] C. Colwell,et al. Region-Specific Myelin Pathology in Mice Lacking the Golli Products of the Myelin Basic Protein Gene , 2005, The Journal of Neuroscience.
[40] C. Campagnoni,et al. The golli-myelin basic protein negatively regulates signal transduction in T lymphocytes , 2004, Journal of Neuroimmunology.
[41] N. Zečević,et al. Identification of Golli and myelin basic proteins in human brain during early development , 2002, Glia.
[42] G. Thomas,et al. Furin at the cutting edge: From protein traffic to embryogenesis and disease , 2002, Nature Reviews Molecular Cell Biology.
[43] J. Strominger,et al. Recognition of the immunodominant myelin basic protein peptide by autoantibodies and HLA-DR2-restricted T cell clones from multiple sclerosis patients. Identity of key contact residues in the B-cell and T-cell epitopes. , 1997, The Journal of clinical investigation.
[44] Theodore V. Tselios,et al. Antagonistic effects of human cyclic MBP(87-99) altered peptide ligands in experimental allergic encephalomyelitis and human T-cell proliferation. , 2002, Journal of medicinal chemistry.
[45] M. D'hooghe,et al. T‐cell reactivity to multiple myelin antigens in multiple sclerosis patients and healthy controls , 2001, Journal of neuroscience research.
[46] D. Pei. Leukolysin/MMP25/MT6-MMP: a novel matrix metalloproteinase specifically expressed in the leukocyte lineage , 1999, Cell Research.
[47] G. Rosenberg. Matrix Metalloproteinases and Neuroinflammation in Multiple Sclerosis , 2002, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[48] C. G. Knight. Active-site titration of peptidases. , 1995, Methods in enzymology.
[49] R. Fridman,et al. Identification and Role of the Homodimerization Interface of the Glycosylphosphatidylinositol-anchored Membrane Type 6 Matrix Metalloproteinase (MMP25)* , 2008, Journal of Biological Chemistry.
[50] Robin J. M. Franklin,et al. Why does remyelination fail in multiple sclerosis? , 2002, Nature Reviews Neuroscience.